Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis

Synopsis

World Market Intelligence's 'Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key competitors, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about 'Genzyme Corporation' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a key competitors section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights

Genzyme Corporation (Genzyme), a subsidiary of Sanofi-Aventis, is a global biotechnology companies. The company develops and applies technologies to encounter unmet deadly diseases. Its products and services are focused on rare genetic disorders, orthopedics, kidney diseases, cancer, organ transplant, diagnostic and predictive testing. In addition, Genzyme focuses on developing products in the areas of neurodegenerative diseases, cardiovascular disease, and other areas of unmet medical needs. The company operates through 65 locations and 11 manufacturing facilities in 40 countries around the world in the US, the UK, Australia, Africa and Europe. Its products are marketed to over 100 countries worldwide. Genzyme is headquartered in Cambridge, Massachusetts, the US.